menu search

Hillstream enters into an exclusive option agreement to acquire a clinical stage asset for chronic pruritis

The post Hillstream Enters into an Exclusive Option Agreement to Acquire a Clinical Stage Asset for Chronic pr...

September 11, 2023, 3:51 pm

Quoin pharmaceuticals provides corporate update and announces second quarter 2023 financial results

Company reports positive clinical data for first subject to complete testing in ongoing open-label Netherton Syndrome study Subject’s skin was asses...

August 2, 2023, 8:45 pm


Search within

Pages Search Results: